|
FAM96A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18380000024843E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.98099999995749E-06 |
| Normal-vs-Stage2 |
3.762600E-01 |
| Normal-vs-Stage3 |
1.95299998395626E-09 |
| Normal-vs-Stage4 |
9.56300000000132E-05 |
| Stage1-vs-Stage2 |
1.890030E-01 |
| Stage1-vs-Stage3 |
3.877900E-02 |
| Stage1-vs-Stage4 |
7.439200E-01 |
| Stage2-vs-Stage3 |
2.691800E-02 |
| Stage2-vs-Stage4 |
1.567980E-01 |
| Stage3-vs-Stage4 |
1.866030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.29669999977034E-08 |
| Normal-vs-AfricanAmerican |
1.686070E-02 |
| Normal-vs-Asian |
3.589500E-02 |
| Caucasian-vs-AfricanAmerican |
4.863000E-01 |
| Caucasian-vs-Asian |
9.297600E-01 |
| AfricanAmerican-vs-Asian |
7.409400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39890000028231E-07 |
| Normal-vs-Female |
5.62559999999213E-05 |
| Male-vs-Female |
5.116200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.79149999996109E-06 |
| Normal-vs-Age(41-60Yrs) |
1.68769999975282E-07 |
| Normal-vs-Age(61-80Yrs) |
2.3000999999967E-05 |
| Normal-vs-Age(81-100Yrs) |
3.561400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.092000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.465800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.978600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.475000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.724600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.496800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.016510E-03 |
| Normal-vs-Grade 2 |
2.9892999999781E-06 |
| Normal-vs-Grade 3 |
1.04519999999386E-06 |
| Normal-vs-Grade 4 |
6.38429999977319E-07 |
| Grade 1-vs-Grade 2 |
3.894000E-01 |
| Grade 1-vs-Grade 3 |
4.033600E-01 |
| Grade 1-vs-Grade 4 |
9.761400E-01 |
| Grade 2-vs-Grade 3 |
9.469400E-01 |
| Grade 2-vs-Grade 4 |
2.104400E-01 |
| Grade 3-vs-Grade 4 |
2.275400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.49719999626075E-08 |
| Normal-vs-ccB subtype |
1.039480E-03 |
| ccA subtype-vs-ccB subtype |
1.526830E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2627999999969E-05 |
| Normal-vs-N1 |
1.362980E-01 |
| N0-vs-N1 |
8.757000E-01 |
|
|
